CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group-Reference-Cited by-同舟云学术

CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

Published:2012-05 Issue:5 Volume:23 Page:1267-1273
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Schmitz N.,Zeynalova S.,Glass B.,Kaiser U.,Cavallin-Stahl E.,Wolf M.,Haenel M.,Loeffler M.,Truemper L.,Pfreundschuh M.

Funder

Deutsche Krebshilfe

German Ministry for Science and Research

Roche

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/5/1267/13785962/mdr440.pdf

Reference26 articles.

1. Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up;Bjorkholm;Ann Oncol,2007

2. Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL);Boehme;Ann Oncol,2007

3. Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516—the Southwest Oncology Group;Bernstein;J Clin Oncol,2009

4. Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab;Feugier;Ann Oncol,2004

5. Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy;Villa;Ann Oncol,2010

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration;Leukemia;2024-08-16

2. Clinical Characteristics and Prognostic Analysis of 24 Cases with Breast Diffuse Large B-cell Lymphoma;2023-10-10

3. Treatment Strategies and Prognostic Factors in Secondary Central Nervous System Lymphoma: A Multicenter Study of 124 Patients;HemaSphere;2023-07-21

4. Prevention and management of secondary central nervous system lymphoma;Haematologica;2022-11-17

5. SOHO State of the Art Updates and Next Questions: Prophylaxis and Management of Secondary CNS Lymphoma;Clinical Lymphoma Myeloma and Leukemia;2022-10